Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 1,552 shares of the firm's stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $18.23, for a total value of $28,292.96. Following the completion of the sale, the chief operating officer directly owned 280,972 shares of the company's stock, valued at $5,122,119.56. This trade represents a 0.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Arteris Stock Performance
Shares of Arteris stock opened at $18.24 on Tuesday. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.85. The stock has a 50 day moving average price of $15.67 and a two-hundred day moving average price of $14.96. The stock has a market capitalization of $829.37 million, a PE ratio of -22.24 and a beta of 1.43.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. Research analysts forecast that Arteris, Inc. will post -0.73 EPS for the current year.
Arteris News Summary
Here are the key news stories impacting Arteris this week:
- Neutral Sentiment: CEO K. Charles Janac sold 9,009 shares at an average $17.65 for $159,009; post-sale ownership ~208,529 shares (−4.14%). The sale was executed under a pre-arranged 10b5-1 plan to cover tax withholding. SEC Filing
- Neutral Sentiment: COO Laurent R. Moll sold 1,552 shares at an average $18.23 for $28,293; post-sale ownership ~280,972 shares (−0.55%). The sale was part of a pre-arranged 10b5-1 plan to cover tax obligations. SEC Filing
- Neutral Sentiment: COO Laurent R. Moll also sold 5,602 shares at $17.65 for $98,875; post-sale ownership ~282,524 shares (−1.94%). Executed under a 10b5-1 plan for tax withholding on vested awards. SEC Filing
- Neutral Sentiment: CFO Nicholas B. Hawkins sold 4,870 shares at $17.65 for $85,956; post-sale ownership ~118,614 shares (−3.94%). Sale made to cover tax withholding and disclosed via SEC filing. SEC Filing
- Neutral Sentiment: VP Paul L. Alpern sold 3,649 shares at $17.65 for $64,405; post-sale ownership ~86,386 shares (−4.05%). Also executed to cover tax withholding on vested awards. SEC Filing
- Neutral Sentiment: CEO K. Charles Janac additionally sold 11,800 shares at $18.34 for $216,412; post-sale ownership ~196,729 shares (−5.66%). Executed under a pre-arranged 10b5-1 plan to cover tax withholding. SEC Filing
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC boosted its position in Arteris by 143.8% in the second quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock worth $1,153,000 after purchasing an additional 71,340 shares during the last quarter. Roubaix Capital LLC purchased a new position in Arteris in the third quarter worth $2,361,000. Granahan Investment Management LLC boosted its position in Arteris by 725.7% in the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company's stock worth $6,278,000 after purchasing an additional 546,341 shares during the last quarter. Herald Investment Management Ltd boosted its position in Arteris by 33.3% in the third quarter. Herald Investment Management Ltd now owns 400,000 shares of the company's stock worth $4,036,000 after purchasing an additional 100,000 shares during the last quarter. Finally, GSA Capital Partners LLP boosted its position in Arteris by 59.3% in the third quarter. GSA Capital Partners LLP now owns 132,079 shares of the company's stock worth $1,334,000 after purchasing an additional 49,153 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company's stock.
Analysts Set New Price Targets
Several brokerages recently issued reports on AIP. Northland Securities set a $24.00 target price on Arteris in a research report on Friday, February 13th. Wall Street Zen raised Arteris from a "hold" rating to a "buy" rating in a research report on Saturday, March 21st. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a research report on Wednesday, January 21st. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $20.00 target price on shares of Arteris in a research report on Friday, February 13th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.17.
Get Our Latest Research Report on Arteris
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
